Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.47 EUR | +0.86% | 0.00% | +5.38% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2021 | 44.63K 47.57K | Sales 2022 | 12.23K 13.04K | Capitalization | 5.91M 6.3M |
---|---|---|---|---|---|
Net income 2021 | -4M -4.26M | Net income 2022 | - 0 | EV / Sales 2021 | 429 x |
Net Debt 2021 | 121K 129K | Net cash position 2022 | 1.84M 1.96M | EV / Sales 2022 | 333 x |
P/E ratio 2021 |
-4.68
x | P/E ratio 2022 |
-7.12
x | Employees | 1 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 40.86% |
1 day | -6.01% | ||
1 week | -6.81% | ||
Current month | +17.11% | ||
1 month | +17.11% | ||
3 months | -15.77% | ||
6 months | -70.20% | ||
Current year | -1.79% |
Managers | Title | Age | Since |
---|---|---|---|
Bruno Rosen
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ralph Bieneck
BRD | Director/Board Member | 56 | - |
Arne Segler
CHM | Chairman | - | - |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.47 | +0.86% | 239 |
24-04-22 | 0.466 | -0.85% | 750 |
24-04-19 | 0.47 | 0.00% | 385 |
24-04-18 | 0.47 | -5.24% | 385 |
24-04-17 | 0.496 | +5.53% | 385 |
Delayed Quote Xetra, April 23, 2024 at 03:32 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-1.79% | 2.55M | |
-0.02% | 42.11B | |
+49.22% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |
- Stock Market
- Equities
- T5O Stock